Furthermore, the RBMS3−/nuclear HIF1A+ patients had the poorest prognosis, which indicated that combined expression of RBMS3 and nuclear HIF1A was a more reliable predictor of GC prognosis, than RBMS3 expression or nuclear HIF1A expression alone. This evidence concerns the gene RBMS3 and gastric cancer.